Director, Real-World Evidence Data Platforms (Fully Remote)

Novartis; Deutschland; Remote; EUR 90.000 - 130.000; Vollzeit

Benefits dieser Stelle

Performance incentives

Impact on patients

Remote flexibility

Zusammenfassung

Novartis is seeking a senior data/health economics professional to help advance scalable real-world data platforms in a global pharmaceutical setting. You will partner with cross-functional teams to align data capabilities with evidence needs and evaluate external data vendors to strengthen data quality standards.

The role requires 7+ years in pharma or healthcare and an advanced degree in health economics or epidemiology, with remote flexibility and a collaborative culture.

Qualifikationen

• 7+ years of experience in pharmaceutical or healthcare sector.
• Strong understanding of RWD sources and their application to RWE.

Aufgaben

• Support development of scalable real-world data platforms.
• Partner with cross-functional teams to align data capabilities with evidence needs.
• Evaluate and onboard external data vendors and strengthen data quality standards.

Ausbildung

Advanced degree in health economics/epidemiology or related field

Jobbeschreibung

• Support development of scalable real-world data platforms.
• Partner with cross-functional teams to align data capabilities with evidence needs.
• Evaluate and onboard external data vendors and strengthen data quality standards.

Qualifications:

• Advanced degree in health economics, epidemiology, or related field.
• 7+ years of experience in pharmaceutical or healthcare sector.
• Strong understanding of RWD sources and their application to RWE.

Why Novartis?:

• Competitive compensation with performance-based incentives.
• Opportunity to impact patient lives through innovative science.
• Collaborative and inclusive culture with remote flexibility.

Novartis

Novartis is a global pharmaceutical company dedicated to improving lives through innovative science. With a large workforce, they foster an inclusive culture that empowers collaboration and bold innovation.